Given the causal role of heparanase in tumor progression in tissues in which cancer-related inflammation typically occurs, (i.e., gastrointestinal tract, pancreas, liver), it is conceivable that inflammation-induced heparanase is involved in coupling inflammation and cancer. Here, HPSE is linked to cancer.